oxybutynin and chlorhexidine

oxybutynin has been researched along with chlorhexidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Eberhart, L; Hörth, D; Kerwat, K; Kerwat, M; Steinfeldt, T; Wiesmann, T; Wulf, H	1

Trials

1 trial(s) available for oxybutynin and chlorhexidine

Article	Year
Chlorhexidine gluconate dressings reduce bacterial colonization rates in epidural and peripheral regional catheters. BioMed research international, 2015, Volume: 2015 Topics: Aged; Anesthesia, Conduction; Anti-Infective Agents, Local; Bacterial Infections; Bandages; Catheter-Related Infections; Chlorhexidine; Delayed-Action Preparations; Dermatologic Agents; Female; Humans; Male; Transdermal Patch; Treatment Outcome	2015

Article

Year

Chlorhexidine gluconate dressings reduce bacterial colonization rates in epidural and peripheral regional catheters.

BioMed research international, 2015, Volume: 2015

Topics: Aged; Anesthesia, Conduction; Anti-Infective Agents, Local; Bacterial Infections; Bandages; Catheter-Related Infections; Chlorhexidine; Delayed-Action Preparations; Dermatologic Agents; Female; Humans; Male; Transdermal Patch; Treatment Outcome

2015

Other Studies

1 other study(ies) available for oxybutynin and chlorhexidine

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011